DISCOVER YOUR NEXT BREAKTHROUGH

Deep Expertise. Customized Solutions.

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next breakthroughs for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development.

We are known for our high quality, cutting-edge translational approach to research, and our customized solutions to support our clients quantify the efficacy of their treatments before they move into the clinic. Our capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. We offer a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.

Key Therapeutic Areas

Our customized preclinical testing services and industry-leading models cover a broad range of therapeutic areas to support your early-stage drug discovery.

Our Technologies and Capabilities

PsychoGenics provides validated disease models and comprehensive, integrated preclinical capabilities to discover the next breakthroughs for several disabling CNS and rare disorders.

/

The Proven Power of Experience

Combine our expertise with yours to discover your next breakthrough.

20+
years of experience

hands-shaking

400+
client relationships with >70% of clients returning

graduation-cap

20%+
team members with a Ph.D.

molecule

30+
disease models

mouse

50+
behavioral assays

Partner with us and transform your program

DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS

Get Started